The Patent Finder

Janssen Pharmaceutica

Also on record
Records under this name other than patents Janssen Pharmaceutica holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Janssen Pharmaceutica

PatentTitleStatus Expires Confidence
US 8,765,979Synthesis of (2S-CIS)-2-(BROMOMETHYL)-2-(4-Chlorophenyl)-1,3 DIOXOLANE-4-Methanol Methanesulfonate(ESTER)
Lapsed on the fee record
Ended Jul 1, 2026 · High confidence
Lapsed on the fee recordEnded Jul 1, 2026High confidence
US 8,653,099Cold Menthol Receptor Antagonists
Lapsed on the fee record
Ended Feb 18, 2026 · High confidence
Lapsed on the fee recordEnded Feb 18, 2026High confidence
US 8,552,032Bicyclic derivatives useful as inhibitors of DPP-1
Lapsed on the fee record
Ended Oct 8, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 8, 2025From the USPTO record
US 7,585,861HIV Inhibiting 1,2,4-Triazines
Formerly held
Term ended
Term ended May 13, 2024 · High confidence
Term endedTerm ended May 13, 2024High confidence
US 9,255,103SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINES PYRAZOLE ANALOGS AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS
Formerly held
Lapsed on the fee record
Ended Feb 9, 2024 · High confidence
Lapsed on the fee recordEnded Feb 9, 2024High confidence
US 9,029,366Substituted Bicyclic Alkoxy Pyrazole Analogs as Allosteric Modulators of MGLUR5 Receptors
Formerly held
Lapsed on the fee record
Ended May 12, 2023 · High confidence
Lapsed on the fee recordEnded May 12, 2023High confidence
US 7,892,779Method of determining chymase activity with secretory leukocyte protease inhibitor
Formerly held
Lapsed on the fee record
Ended Feb 22, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 22, 2023From the USPTO record
US 7,892,826Human cell clones having an endogeneous urotensin II receptor
Formerly held
Lapsed on the fee record
Ended Feb 22, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 22, 2023From the USPTO record
US 7,125,891Tripeptidyl peptidase inhibitors
Formerly held
Term ended
Term ended Aug 28, 2022 · From the USPTO record
Term endedTerm ended Aug 28, 2022From the USPTO record
US 8,703,946Substituted Pyrazolo[1,5-a]pyrazine Compounds as Allosteric Modulators of MGLUR5 Receptors
Formerly held
Lapsed on the fee record
Ended Apr 22, 2022 · High confidence
Lapsed on the fee recordEnded Apr 22, 2022High confidence
10 of 71 patents shown.
Pro members see all 71.
Pro members: see all 71 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited